Search results
Showing 76 to 86 of 86 results for pulmonary hypertension
Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates (IPG246)
Evidence-based recommendations on hybrid procedure for interim management of hypoplastic left heart syndrome in neonates. This involves placing bands around the branches of the pulmonary artery and inserting stents to keep the ductus arteriosus open.
View recommendations for IPG246Show all sections
Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) (IPG192)
Evidence-based recommendations on therapeutic amnioinfusion for treating oligohydramnios during pregnancy (excluding labour). This involves injecting a substance similar to amniotic fluid into the space around the baby.
View recommendations for IPG192Show all sections
Sections for IPG192
Living-donor lung transplantation for end-stage lung disease (IPG170)
Evidence-based recommendations on living-donor lung transplantation for end-stage lung disease. This involves removing a lung from each of the two donors and replacing the recipient's lungs with the donor lungs.
View recommendations for IPG170Show all sections
Sections for IPG170
Balloon dilatation of systemic to pulmonary arterial shunts in children (IPG77)
Evidence-based recommendations on balloon dilatation of systemic to pulmonary arterial shunts in children. This involves inflating a balloon inserted into the area so blood can flow through more easily.
View recommendations for IPG77Show all sections
Sections for IPG77
adults: investigation and management - To be confirmed Hypertension in adults: diagnosis and management - To be confirmed
Treprostinil diethanolamine for treating pulmonary arterial hypertension TS ID 11772
Awaiting development [GID-TA11123] Expected publication date: TBC
Drugs for the treatment of pulmonary arterial hypertension [ID12]
Discontinued [GID-TAG382]
Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]
Suggested remit: To appraise the clinical and cost effectiveness of treprostinil sodium within its marketing authorisation for treating chronic thromboembolic p...
Sotatercept for treating pulmonary arterial hypertension [ID6163]
In development [GID-TA11103] Expected publication date: 19 March 2025